Autolus Therapeutics (AUTL) Prepaid Assets (2017 - 2025)
Autolus Therapeutics (AUTL) posted quarterly Prepaid Assets of $76.5 million for Q4 2025, up 13.58% year-on-year from $67.3 million in Q4 2024, and down 10.39% on a QoQ basis from $85.3 million in Q3 2025.
Autolus Therapeutics (AUTL) Prepaid Assets (2017 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has reported Prepaid Assets for 9 consecutive years, with $76.5 million the latest figure, recorded in Q4 2025.
- Quarterly Prepaid Assets rose 13.58% year-over-year to $76.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $76.5 million (up 13.58% YoY) and the FY2025 annual result came in at $76.5 million, up 13.58% from the prior year.
- Prepaid Assets fell to $76.5 million in Q4 2025 per AUTL's latest filing, from $85.3 million in the prior quarter.
- Over the last five years, Prepaid Assets for AUTL reached as high as $85.3 million in Q3 2025 and fell as low as $35.0 million in Q4 2023.
- A 5-year average of $54.1 million and a median of $51.0 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets slipped 24.01% — and 2024, when it soared 92.55%.
- Year by year, Prepaid Assets stood at $36.3 million in 2021, then gained by 18.56% to $43.0 million in 2022, then fell by 18.7% to $35.0 million in 2023, then soared by 92.55% to $67.3 million in 2024, then gained by 13.58% to $76.5 million in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $76.5 million, $85.3 million, and $67.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76.47 Mn |
| Sep 30, 2025 | 85.34 Mn |
| Jun 30, 2025 | 67.88 Mn |
| Mar 31, 2025 | 68.78 Mn |
| Dec 31, 2024 | 67.33 Mn |
| Sep 30, 2024 | 59.58 Mn |
| Jun 30, 2024 | 51.64 Mn |
| Mar 31, 2024 | 44.75 Mn |
| Dec 31, 2023 | 34.97 Mn |
| Sep 30, 2023 | 51.53 Mn |
| Jun 30, 2023 | 47.53 Mn |
| Mar 31, 2023 | 50.53 Mn |
| Dec 31, 2022 | 43.01 Mn |
| Sep 30, 2022 | 48.94 Mn |
| Jun 30, 2022 | 42.20 Mn |
| Mar 31, 2022 | 40.57 Mn |
| Dec 31, 2021 | 36.28 Mn |
| Sep 30, 2021 | 64.41 Mn |
| Jun 30, 2021 | 52.94 Mn |
| Mar 31, 2021 | 48.26 Mn |